What are the Benefits of Bevacizumab in Gynecologic Oncology?
Clinical trials have shown that bevacizumab can extend progression-free survival in patients with advanced ovarian cancer. It has been particularly beneficial in cases where the cancer is resistant to other treatments. By inhibiting angiogenesis, bevacizumab helps to starve the tumor of the nutrients and oxygen it needs to grow.
